Rituximab Plus Fludarabine and Cyclophosphamide Prolongs Progression-Free Survival Compared With Fludarabine and Cyclophosphamide Alone in Previously Treated Chronic Lymphocytic Leukemia

Chronic lymphocytic leukemia: ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up

(2009) B. Eichhorst et al.   ANNALS OF ONCOLOGY

How I treat CLL up front

(2009) J. G. Gribben   BLOOD

EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary

(2009) Milena Sant et al.   EUROPEAN JOURNAL OF CANCER

Rituximab, Fludarabine, Cyclophosphamide, and Mitoxantrone: A New, Highly Active Chemoimmunotherapy Regimen for Chronic Lymphocytic Leukemia

(2009) Francesc Bosch et al.   JOURNAL OF CLINICAL ONCOLOGY

Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia

(2008) C. S. Tam et al.   BLOOD

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

(2008) M. Hallek et al.   BLOOD

Other Malignancies in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

(2008) Apostolia-Maria Tsimberidou et al.   JOURNAL OF CLINICAL ONCOLOGY

Rituximab in combination with high-dose methylprednisolone for the treatment of fludarabine refractory high-risk chronic lymphocytic leukemia

(2008) J E Castro et al.   LEUKEMIA